Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of 72-hour intravenous MCI-186 infusion in acute ischemic stroke
NL-OMON35656Phase 2Active, not recruiting
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone in ischemic stroke, sponsored by Mitsubishi Tanabe Pharma. Started Apr 2009; status: active, not recruiting.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON35656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35656.